(19)
(11)
EP 1 104 293 A1
(12)
(43)
Date of publication:
06.06.2001
Bulletin 2001/23
(21)
Application number:
99941081.4
(22)
Date of filing:
13.08.1999
(51)
International Patent Classification (IPC)
7
:
A61K
31/00
,
A61K
31/69
,
A61K
38/55
,
A61P
37/00
,
A61P
37/08
,
A61P
29/00
,
A61P
35/00
,
A61P
1/00
,
A61P
9/10
,
A61P
31/00
,
A61P
31/12
,
A61P
43/00
(86)
International application number:
PCT/US9918/315
(87)
International publication number:
WO 0010/549
(
02.03.2000
Gazette 2000/09)
(84)
Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI
(30)
Priority:
21.08.1998
US 97376 P
(71)
Applicant:
Point Therapeutics, Inc.
Boston, MA 02111 (US)
(72)
Inventor:
WALLNER, Barbara
Weston, MA 02193 (US)
(74)
Representative:
Jump, Timothy John Simon et al
Venner Shipley & Co.20 Little Britain
London EC1A 7DH
London EC1A 7DH (GB)
(54)
REGULATION OF SUBSTRATE ACTIVITY